Gender, age, and ethnicity in HIV vaccine-related research and clinical trials: Report from a WHO-UNAIDS consultation, 26-28 August 2004. Lausanne, Switzerland

AIDS

Volumn 19, Issue 17, 2005, Pages

  Osmanov, S ^a  

^a UNAIDS   (Switzerland)

Author keywords

Age; Clinical trials; Community preparedness; Ethics; Ethnicity; Gender; HIV vaccines; Regulatory aspects; Vaccine efficacy

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HERPES SIMPLEX VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MENINGITIS VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE;

BOTSWANA; BRAZIL; CHINA; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DIPHTHERIA; GOVERNMENT; HEALTH CARE POLICY; HEPATITIS A; HEPATITIS B; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFLUENZA; MEDICAL ETHICS; MEDICAL RESEARCH; MENINGITIS; PRIORITY JOURNAL; RUBELLA; SOCIAL BEHAVIOR; SOUTH AFRICA; STREPTOCOCCUS INFECTION; SWITZERLAND; TETANUS; THAILAND; TUBERCULOSIS; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

EID: 27944488350     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000189853.29064.a8     Document Type: Conference Paper

References (15)

1. Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 1999; 18:3263-3282.
2. Brisson M, Edmunds WJ. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making 2003; 23:76-82.
3. McLean AR, Blower SM. Imperfect vaccines and herd immunity to HIV. Proc R Soc Lond B Biol Sci 1993; 253:9-13.
4. Anderson RM, Swinton J, Garnett GP. Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection. Proc R Soc Lond B Biol Sci 1995; 261:147-151.
5. Barth-Jones DC, Adams AL, Koopman JS. Monte-carlo simulation experiments for analysis of HIV vaccine effects and vaccine trial design. In Proceedings of the 2000 Winter Simulation Conference. Edited by Joines JA, Barton RR, Kang K, Fishwick PA. Orlando. 2000:1985-1994.
6. Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, Peyerl FW, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002; 415:335-339.
7. Halloran ME, Struchiner CJ, Longini IM. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 1997; 146:789-803.
8. van Ballegooijen M, Bogaards JA, Weverling GJ, Boerlijst MC, Goudsmit J. AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination. J Acquir Immune Defic Syndr 2003; 34:214-220.
9. Barth-Jones DC, Longini IM. Determining optimal vaccination policy for HIV vaccines: A dynamic simulation model for the evaluation of vaccination policy. 2002 International Conference on Health Sciences Simulation. San Antonio, TX, January 2002:63-79.
10. WHO-UNAIDS collaborative group. Cost effectiveness and delivery study for future HIV vaccines. AIDS, 2005; 19:w1-w6.
11. Fuchs J, Durham M, McLellan-Lemal E, Vittinghoff E, Buchbinder S, Vax Study Team. Younger HIV vaccine trial participants report negative social impacts. XV International AIDS Conference. Bangkok, July 2004 [abstract ThPeC7444].
12. Chesney MA, Chambers D, Kahn J. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. J Acquir Immune Defic Syndr 1997; 16:266-271.
13. Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, et al. HIV sexual risk behavior over 36-months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (in press).
14. Buchbinders, Wheeler S, Vittinghoff E, McKirnan D, Celum C, Mayer K, et al. Declines in risk behavior are smaller in phase III vaccine trials participants than in a non-vaccine trial control group. AIDS Vaccine 2003. New York Abstract 56.
15. McClure C, Gray G, Rybczyk GK, Wright P. Challenges to conducting HIV preventive trials with adolescents. J Acquir Immune Defic Syndr 2004; 36:726-733.